These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6143176)

  • 21. Observations on the presence of immunity in rats to Angiostrongylus cantonensis (Chen).
    Ow Yang CK; Lim BL; Lie Kian Joe
    Med J Malaya; 1965 Sep; 20(1):70. PubMed ID: 4221428
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological study of human strongyloidiasis. I. Analysis of IgE levels.
    Carneiro Leao R; de Toledo Barras MM; Mendes E
    Allergol Immunopathol (Madr); 1980; 8(1):31-4. PubMed ID: 7405758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strongyloidiasis with massive hyperinfection.
    Dwork KG; Jaffe JR; Lieberman HD
    N Y State J Med; 1975 Jul; 75(8):1230-4. PubMed ID: 1094342
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoblot analysis of antibodies in human strongyloidiasis.
    Sato Y; Inoue F; Matsuyama R; Shiroma Y
    Trans R Soc Trop Med Hyg; 1990; 84(3):403-6. PubMed ID: 2260175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: Effect of corticosteroids on experimental strongyloidiasis.
    Moqbel R
    Parasitology; 1974 Oct; 69(2):xviii. PubMed ID: 4419361
    [No Abstract]   [Full Text] [Related]  

  • 26. Determinants of reactivation of inapparent Strongyloides stercoralis infection in patients hospitalized for unrelated admitting diagnosis.
    Rets A; Gupta R; Haseeb MA
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1279-85. PubMed ID: 24081104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A disseminated strongyloidiasis in a non immunocompromised patient].
    Duquenne J; Mabalukwa J; Calvo E; Michaux C; Staub T
    Rev Med Liege; 2018 Jul; 73(7-8):383-386. PubMed ID: 30113779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Strongyloidiasis in the immunologically compromised patient].
    Quiñones Soto RA; Harrington PT; Gutiérrez Núñez JJ; Ramírez Ronda CH; Bermúdez RH
    Bol Asoc Med P R; 1981 Nov; 73(11):562-6. PubMed ID: 6950729
    [No Abstract]   [Full Text] [Related]  

  • 29. [A new case of strongyloidiasis in an immunosuppressed patient].
    Huarte MP; Vidán JR; Guerra A; Fortún MT
    Rev Esp Enferm Apar Dig; 1988 Sep; 74(3):289. PubMed ID: 3205954
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA).
    Sato Y; Takara M; Otsuru M
    Trans R Soc Trop Med Hyg; 1985; 79(1):51-5. PubMed ID: 3992642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Passive transfer of immunity to N. brasiliensis (Travassos, 1914) from mother rats to offspring.
    Greenberg Z
    J Parasitol; 1971 Jun; 57(3):685-6. PubMed ID: 5104562
    [No Abstract]   [Full Text] [Related]  

  • 32. Eosinophil-selective mediators in human strongyloidiasis.
    Mir A; Benahmed D; Igual R; Borrás R; O'Connor JE; Moreno MJ; Rull S
    Parasite Immunol; 2006 Aug; 28(8):397-400. PubMed ID: 16879311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal strongyloidiasis after renal transplantation: a complication of immunosuppression.
    White JV; Garvey G; Hardy MA
    Am Surg; 1982 Jan; 48(1):39-41. PubMed ID: 7039442
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular responses in human strongyloidiasis.
    Genta RM; Ottesen EA; Neva FA; Walzer PD; Tanowitz HB; Wittner M
    Am J Trop Med Hyg; 1983 Sep; 32(5):990-4. PubMed ID: 6625079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans.
    Neva FA; Gam AA; Burke J
    J Infect Dis; 1981 Nov; 144(5):427-32. PubMed ID: 7031142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strongyloidiasis with emphasis on human infections and its different clinical forms.
    Toledo R; Muñoz-Antoli C; Esteban JG
    Adv Parasitol; 2015 Apr; 88():165-241. PubMed ID: 25911368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated strongyloidiasis in a immunocompromised host.
    Mundkur SC; Aroor S; Jayashree K
    Indian Pediatr; 2011 Dec; 48(12):974-6. PubMed ID: 22253157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic strongyloidiasis. Hyperinfection syndrome and disseminated strongyloidiasis].
    Hagelskjaer LH
    Ugeskr Laeger; 1993 Aug; 155(35):2715-6. PubMed ID: 8212390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why does HIV infection not lead to disseminated strongyloidiasis?
    Viney ME; Brown M; Omoding NE; Bailey JW; Gardner MP; Roberts E; Morgan D; Elliott AM; Whitworth JA
    J Infect Dis; 2004 Dec; 190(12):2175-80. PubMed ID: 15551217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology and immunology of human strongyloidiasis.
    Neva FA
    J Infect Dis; 1986 Mar; 153(3):397-406. PubMed ID: 3081656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.